Antiandrogen monotherapy: recommendations for the treatment of prostate cancer.
about
Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancerInterventions for sexual dysfunction following treatments for cancerInterventions for sexual dysfunction following treatments for cancerCurrent management of castrate-resistant prostate cancer.The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptor.Safety and tolerability of intermittent androgen deprivation therapy: a literature review.Overview of the latest treatments for castration-resistant prostate cancer.
P2860
Q24193722-6E2FA1F2-84E4-4C4D-B692-64508FF2355FQ24242883-6DFF0518-D157-4DBF-A352-E74944A343C2Q24246178-50B8A481-F62B-4E05-B176-01D161017E8FQ34111641-78E40E92-ACCC-45D3-BC6A-9964488DD710Q36126914-B9EC31DF-964B-4663-AB97-8993BEAD3993Q37995670-B94079B7-30E8-436B-B07F-8368928DA981Q38116754-5B581C19-001F-43C6-AAC7-603130B5855F
P2860
Antiandrogen monotherapy: recommendations for the treatment of prostate cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Antiandrogen monotherapy: recommendations for the treatment of prostate cancer.
@ast
Antiandrogen monotherapy: recommendations for the treatment of prostate cancer.
@en
type
label
Antiandrogen monotherapy: recommendations for the treatment of prostate cancer.
@ast
Antiandrogen monotherapy: recommendations for the treatment of prostate cancer.
@en
prefLabel
Antiandrogen monotherapy: recommendations for the treatment of prostate cancer.
@ast
Antiandrogen monotherapy: recommendations for the treatment of prostate cancer.
@en
P356
P1476
Antiandrogen monotherapy: recommendations for the treatment of prostate cancer.
@en
P2093
Antonio Cardi
Franco Di Silverio
P356
10.1159/000075960
P577
2004-01-01T00:00:00Z